Adalimumab Shows Efficacy for Ileal Pouch Crohn Disease
Complete response was 50% for induction therapy and 33% for maintenance therapy.
Citalopram Reduces GERD Symptoms in Hypersensitive Esophagus
This selective serotonin reuptake inhibitor showed promise in a small clinical trial of patients who did not respond to acid suppressants.